Accuray Incorporated
$ 0.37
-7.18%
03 Jun - close price
- Market Cap 47,371,300 USD
- Current Price $ 0.37
- High / Low $ 0.39 / 0.36
- Stock P/E N/A
- Book Value 0.35
- EPS -0.38
- Next Earning Report 2026-08-12
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.02 %
- ROE -1.01 %
- 52 Week High 2.10
- 52 Week Low 0.25
About
Accuray Incorporated designs, develops and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa and the rest of the Asia Pacific region. The company is headquartered in Sunnyvale, California.
Analyst Target Price
$0.35
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-06 | 2026-02-04 | 2025-11-05 | 2025-08-13 | 2025-04-30 | 2025-02-05 | 2024-11-06 | 2024-08-13 | 2024-05-01 | 2024-01-31 | 2023-11-07 | 2023-08-09 |
| Reported EPS | -0.07 | -0.11 | -0.14 | 0.01 | -0.01 | 0.02 | -0.04 | 0.03 | -0.06 | -0.1 | -0.03 | -0.02 |
| Estimated EPS | -0.05 | -0.11 | -0.05 | 0.02 | -0.04 | -0.04 | -0.06 | 0.03 | -0.02 | -0.04 | -0.05 | 0.01 |
| Surprise | -0.02 | 0 | -0.09 | -0.01 | 0.03 | 0.06 | 0.02 | 0 | -0.04 | -0.06 | 0.02 | -0.03 |
| Surprise Percentage | -40% | 0% | -180% | -50% | 75% | 150% | 33.3333% | 0% | -200% | -150% | 40% | -300% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-12 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | -0.03 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ARAY
2026-05-30 07:39:05
Accuray Incorporated announced an inducement award granted to new employee Paul Krauss, consisting of 200,000 restricted stock units. This award, made under NASDAQ Listing Rule 5635(c)(4), will vest over four years based on continuous employment and is separate from the company's 2022 Equity Incentive Plan.
2026-05-29 23:39:30
Accuray (NASDAQ: ARAY) has granted its Senior Vice President and Chief Commercial Officer, Paul Michael Miele, 650,000 restricted stock units (RSUs). These RSUs represent a contingent right to receive one share of common stock each and are an equity-based compensation award designed to align Miele's compensation with the company's long-term share performance. The RSUs will vest in quarterly installments, with the first portion vesting on April 30, 2027, and subsequent portions vesting on the first, second, and third anniversaries of that date.
2026-05-29 20:39:30
Accuray Incorporated has reported inducement awards to its new Chief Commercial Officer, Paul Miele, and new Chief Legal Officer, David Shin, as required by NASDAQ Listing Rules. These equity awards, comprised of restricted stock units (RSUs) and performance-based restricted stock units (PSUs), were granted to incentivize them to join the company. The awards are subject to vesting schedules and performance criteria, aligning with the company's existing equity incentive plan terms.
2026-05-29 20:39:30
Accuray Incorporated has reported an inducement award as required by Nasdaq Listing Rules. The article, provided by Refinitiv and distributed via Reuters, states this information succinctly. Further details are contingent on logging in or creating an account.
2026-05-29 20:09:26
Accuray stock fell following an earnings miss and withdrawal of guidance. The company reported a Q4 loss and lower than expected revenue, impacting investor confidence.
2026-05-29 20:09:26
This page provides a detailed financial overview of Accuray Inc (ARAY), including its current stock price, key financial metrics, insider transactions, and a history of analyst ratings. It also lists recent news articles and press releases related to the company's activities, such as inducement awards, research agreements, and financial results.
